Andrey Tomilov
Research Subjects
Andrey Tomilov has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- E. I. Veliev
S.P. Botkin Moscow Multidisciplinary Scientific and Clinical Center, Moscow Healthcare Department; Department of Urology and Surgical Andrology, Russian Medical Academy of Continuous Professional Education, Ministry of Health of Russia
9 shared publications - Elena N. Golubtsova
Moscow Urological Center, S.P. Botkin Moscow Multidisciplinary Scientific and Clinical Center, Moscow Healthcare Department
7 shared publications - Andrey Borisovich Bogdanov
Botkin Moscow Multidisciplinary Scientific and Clinical Centre; Russian Medical Academy of Continuous Professional Education
2 shared publications - Bagrat Grigoryan
Botkin Hospital Moscow Urology Center, Moscow, Russia
2 shared publications E I Veliev
2 shared publications- E N Golubtsova
Russian Medical Academy of Continuous Professional Education, department of urology and surgical andrology, Moscow, Russia
2 shared publications
Latest Publications
- 25 December 2025
- Published by UroMedia LLC in Experimental and Сlinical Urology
- Vol. 18 (4)
Possibilities of an intraoperative personalized approach to achieving the tri-perfect results of robot-assisted radical prostatectomy.
Introduction. Since the introduction of robot-assisted prostatectomy, ongoing improvement of surgical intervention techniques has continued. The effectiveness of the operation is determined by both oncological safety and functional results. The development of an intraoperative per- sonalized approach for the fastest possible of urinary continence recovery and erectile function, without compromising the oncological results of surgery, remains an urgent issue. Results. We described a case of robot-assisted radical prostatectomy with the technique of partial sparing of Retzius space, intraoperative assessment of the surgical margin using the CYCLOP method, lateral reconstruction of the urethrovesical anastomosis and provides a literature review. Discussion. The evolution of nerve-sparing radical prostatectomy techniques is focused on preserving as many nerves as possible, which are in- volved in continence and erectile function. It is important to adhere to the principles of radicality, which is ensured, among other things, by the availability of rapid intraoperative histological examination. Currently known reconstructive techniques for creating urethrovesical anastomosis are not without their drawbacks. Therefore, the development of optimal techniques is ongoing. Conclusion. The development of an intraoperative strategy for a personalized approach to achieving the trifecta of RPPE results will improve the functional outcomes of the surgery without affecting the oncological radicality.
- 25 December 2025
- Published by UroMedia LLC in Experimental and Сlinical Urology
- Vol. 18 (4)
Possibilities of an intraoperative personalized approach to achieving the tri-perfect results of robot-assisted radical prostatectomy.
Introduction. Since the introduction of robot-assisted prostatectomy, ongoing improvement of surgical intervention techniques has continued. The effectiveness of the operation is determined by both oncological safety and functional results. The development of an intraoperative per- sonalized approach for the fastest possible of urinary continence recovery and erectile function, without compromising the oncological results of surgery, remains an urgent issue. Results. We described a case of robot-assisted radical prostatectomy with the technique of partial sparing of Retzius space, intraoperative assessment of the surgical margin using the CYCLOP method, lateral reconstruction of the urethrovesical anastomosis and provides a literature review. Discussion. The evolution of nerve-sparing radical prostatectomy techniques is focused on preserving as many nerves as possible, which are in- volved in continence and erectile function. It is important to adhere to the principles of radicality, which is ensured, among other things, by the availability of rapid intraoperative histological examination. Currently known reconstructive techniques for creating urethrovesical anastomosis are not without their drawbacks. Therefore, the development of optimal techniques is ongoing. Conclusion. The development of an intraoperative strategy for a personalized approach to achieving the trifecta of RPPE results will improve the functional outcomes of the surgery without affecting the oncological radicality.
- Open Access
- 9 May 2025
- Published by Publishing House ABV Press in Cancer Urology
- Vol. 21 (1) , 112-118
Clinical case of artificial urinary sphincter function restoration in a patient with urethral destruction at the cuff site
Implantation of an artificial urinary sphincter is the most studied and most effective method of surgical treatment of severe stress urinary incontinence in men. If urethral erosion develops at the cuff site, it is only possible to restore the device’s function and regain the previous level of quality of life through a multi-stage procedure.This paper describes a clinical case of multistage treatment of a patient with urethral erosion at the site of the artificial urinary sphincter cuff and provides a review of the literature.
- 9 May 2025
- Published by Publishing House ABV Press in Cancer Urology
- Vol. 21 (1) , 112-118
Open AccessClinical case of artificial urinary sphincter function restoration in a patient with urethral destruction at the cuff site
Implantation of an artificial urinary sphincter is the most studied and most effective method of surgical treatment of severe stress urinary incontinence in men. If urethral erosion develops at the cuff site, it is only possible to restore the device’s function and regain the previous level of quality of life through a multi-stage procedure.This paper describes a clinical case of multistage treatment of a patient with urethral erosion at the site of the artificial urinary sphincter cuff and provides a review of the literature.
- Open Access
- 2 March 2025
- Published by Rostov State Medical University in Urology Herald
- Vol. 13 (1) , 56-62
Revision of the artificial urinary sphincter in men: a long-term experience from a single centre
Introduction. Implantation of an artificial urinary sphincter (AUS) is the main treatment method of surgical treatment in men with moderate to severe stress urinary incontinence. Despite its efficacy, implantation is sometimes accompanied by the development of complications, which in some cases necessitate revisions and removal of the entire device or its components.Objective. To evaluate the outcomes of AUS implantation regarding safety and the need for re-interventions at long-term follow-up.Materials & methods. From 2004 to 2023, AUS was implanted in 62 patients with severe stress urinary incontinence. Complications are described according to the Clavien-Dindo classification. Revisions followed replacement of components or the entire AUS in the absence of signs of infection and revisions followed components or entire AUS explanation in case of infection were registered.Results. The mean patient age at the time of implantation was 67.4±8years. With amedian follow-up time of 73.5months (IQR 14.8 – 118.3 months), complications were noted in 22 (35.5%) patients, and 33 revisions were performed. The median time to complication requiring replacement of the AUS or its components was 60 months (IQR 50 – 94 months). The median time to complication requiring removal of the AUS or its components was 31 months (IQR 8 – 83 months). A statistically significant effect of type 2diabetes mellitus on AUS component replacement was revealed (OR 4.9, pConclusions. AUS implantation is associated with the development of complications that necessitate revision. These complications account for roughly one-third of all AUS interventions. Revision operations contribute to restoring AUS functionality and enhancing patients' quality of life. Given the inadequacy of applying the general surgical classification of complications to men undergoing surgical treatment for urinary incontinence, there is a need to modify the documentation and classification of such complications.
- 2 March 2025
- Published by Rostov State Medical University in Urology Herald
- Vol. 13 (1) , 56-62
Open AccessRevision of the artificial urinary sphincter in men: a long-term experience from a single centre
Introduction. Implantation of an artificial urinary sphincter (AUS) is the main treatment method of surgical treatment in men with moderate to severe stress urinary incontinence. Despite its efficacy, implantation is sometimes accompanied by the development of complications, which in some cases necessitate revisions and removal of the entire device or its components.Objective. To evaluate the outcomes of AUS implantation regarding safety and the need for re-interventions at long-term follow-up.Materials & methods. From 2004 to 2023, AUS was implanted in 62 patients with severe stress urinary incontinence. Complications are described according to the Clavien-Dindo classification. Revisions followed replacement of components or the entire AUS in the absence of signs of infection and revisions followed components or entire AUS explanation in case of infection were registered.Results. The mean patient age at the time of implantation was 67.4±8years. With amedian follow-up time of 73.5months (IQR 14.8 – 118.3 months), complications were noted in 22 (35.5%) patients, and 33 revisions were performed. The median time to complication requiring replacement of the AUS or its components was 60 months (IQR 50 – 94 months). The median time to complication requiring removal of the AUS or its components was 31 months (IQR 8 – 83 months). A statistically significant effect of type 2diabetes mellitus on AUS component replacement was revealed (OR 4.9, pConclusions. AUS implantation is associated with the development of complications that necessitate revision. These complications account for roughly one-third of all AUS interventions. Revision operations contribute to restoring AUS functionality and enhancing patients' quality of life. Given the inadequacy of applying the general surgical classification of complications to men undergoing surgical treatment for urinary incontinence, there is a need to modify the documentation and classification of such complications.
- 31 December 2024
- Published by Bionika Media in Urologiia
- Vol. 6_2024
Long-term functional results of artificial urinary sphincter implantation in men
- 31 December 2024
- Published by Bionika Media in Urologiia
- Vol. 6_2024
Long-term functional results of artificial urinary sphincter implantation in men
- Open Access
- 1 December 2024
- Published by Publishing House ABV Press in Cancer Urology
- Vol. 20 (4) , 127-131
Problems of classification and reporting of complications of surgical treatment of urinary incontinence in men
Stress urinary incontinence extremely negatively affects the quality of life of patients who underwent surgical treatment of malignant and benign tumors of the prostate. Surgical treatment of incontinence usually involves implantation of an artificial urinary sphincter or sling which can also cause complications. Reporting and classification of surgical complications after urinary incontinence treatment are important for systemization, evaluation, and comparison of different studies and techniques, and the current surgical Clavien-Dindo classification of complications does not take into account specifics of management of these patients and the role of infection. The developed classification is based on the principle of grading of complications depending on treatment used for its elimination (if it requires invasive intervention or not) and considers specifics of complications accompanied by infection.
- 1 December 2024
- Published by Publishing House ABV Press in Cancer Urology
- Vol. 20 (4) , 127-131
Open AccessProblems of classification and reporting of complications of surgical treatment of urinary incontinence in men
Stress urinary incontinence extremely negatively affects the quality of life of patients who underwent surgical treatment of malignant and benign tumors of the prostate. Surgical treatment of incontinence usually involves implantation of an artificial urinary sphincter or sling which can also cause complications. Reporting and classification of surgical complications after urinary incontinence treatment are important for systemization, evaluation, and comparison of different studies and techniques, and the current surgical Clavien-Dindo classification of complications does not take into account specifics of management of these patients and the role of infection. The developed classification is based on the principle of grading of complications depending on treatment used for its elimination (if it requires invasive intervention or not) and considers specifics of complications accompanied by infection.
- Open Access
- 28 October 2024
- Published by Elsevier in Continence
- Vol. 12
Pragmatic reporting system for complications of male stress urinary incontinence surgeries (COMUS)
- 28 October 2024
- Published by Elsevier in Continence
- Vol. 12
Open AccessPragmatic reporting system for complications of male stress urinary incontinence surgeries (COMUS)
- Open Access
- 17 May 2024
- Published by Publishing House ABV Press in Cancer Urology
- Vol. 20 (1) , 134-139-139
Clinical case of primary transcorporal artificial urinary sphincter cuff implantation
Among surgical methods of treatment of male stress urinary incontinence, implantation of an artificial urinary sphincter is the leading technique. Despite its acceptable effectiveness, the intervention carries a risk of complications, some of which require removal of a component or the entire device.The article presents a clinical case of primary artificial urinary sphincter cuff placement and literature review on this topic.
- 17 May 2024
- Published by Publishing House ABV Press in Cancer Urology
- Vol. 20 (1) , 134-139-139
Open AccessClinical case of primary transcorporal artificial urinary sphincter cuff implantation
Among surgical methods of treatment of male stress urinary incontinence, implantation of an artificial urinary sphincter is the leading technique. Despite its acceptable effectiveness, the intervention carries a risk of complications, some of which require removal of a component or the entire device.The article presents a clinical case of primary artificial urinary sphincter cuff placement and literature review on this topic.
- Open Access
- 5 March 2024
- Published by Rostov State Medical University in Urology Herald
- Vol. 12 (1) , 91-97
Artificial urinary sphincter implantation: outcomes evaluation in a cohort of patients beyond a ten-year follow-up
Introduction. Implantation of an artificial urinary sphincter (AUS) is the main treatment method for patients with intrinsic sphincteric deficiency. There are few studies investigating the effectiveness, safety, and impact on the quality of life of the AUS implantation beyond a ten-year follow-up.Objective. To evaluate the outcomes of the AUS implantation in terms of safety, efficacy, and impact on quality of life in a group of patients beyond a ten-year follow-up.Materials & methods. From 2004 to 2023, AUS were implanted in 62 patients with severe stress urinary incontinence, of whom 14 had a follow-up period of more than 10 years. Urine loss is estimated using bladder diary. The use of ≤1 pad per day (“social continence”) was considered as cure. The quality of life was assessed using the IPSS-QoL scale and the ICIQ-UI SF questionnaire. Complications are described according to the Clavien-Dindo classification.Results. The median age of the patient at the time of implantation was 66 [63; 68] years. The causes of severe stress urinary incontinence were the following interventions: radical prostatectomy — 11 patients, radical cystectomy — two patients, transurethral resection of the prostate — one patient. The median time after the intervention that caused urinary incontinence was 20 [15; 26] months. The effectiveness of implantation was evaluated in 11 patients, three patients had complications preventing the use of the AUS. Median follow-up was 137 [124; 160] months. There was a statistically significant decrease in the median urine loss from 700,0 [600; 800] to 12,5 [1; 60] ml. There was also a significant reduction in the use of pads per day from 7 [7; 8] to 1 [0; 2]. Five patients did not use pads. Seven patients met the criterion of cure. Median IPSS-QoL scores decreased from 4 [4; 5] to 2 [1; 2]. After treatment, the score of the ICIQ-UI SF questionnaire was 8 [6; 10]. Complications superior to Clavien-Dindo II were noted in 8 of 14 patients. Eight patients underwent 15 revisions, six of them repeated. The AUS was partially or completely removed in six patients.Conclusions. Over a ten-year follow-up period, a significant number of patients developed complications, including those requiring removal or replacement of the AUS or its components, and therefore patients with an AUS require regular long-term follow-up. Despite a significant proportion of patients who required an AUS revision, implantation leads to a statistically significant reduction in urine loss and an improvement in the quality of life.
- 5 March 2024
- Published by Rostov State Medical University in Urology Herald
- Vol. 12 (1) , 91-97
Open AccessArtificial urinary sphincter implantation: outcomes evaluation in a cohort of patients beyond a ten-year follow-up
Introduction. Implantation of an artificial urinary sphincter (AUS) is the main treatment method for patients with intrinsic sphincteric deficiency. There are few studies investigating the effectiveness, safety, and impact on the quality of life of the AUS implantation beyond a ten-year follow-up.Objective. To evaluate the outcomes of the AUS implantation in terms of safety, efficacy, and impact on quality of life in a group of patients beyond a ten-year follow-up.Materials & methods. From 2004 to 2023, AUS were implanted in 62 patients with severe stress urinary incontinence, of whom 14 had a follow-up period of more than 10 years. Urine loss is estimated using bladder diary. The use of ≤1 pad per day (“social continence”) was considered as cure. The quality of life was assessed using the IPSS-QoL scale and the ICIQ-UI SF questionnaire. Complications are described according to the Clavien-Dindo classification.Results. The median age of the patient at the time of implantation was 66 [63; 68] years. The causes of severe stress urinary incontinence were the following interventions: radical prostatectomy — 11 patients, radical cystectomy — two patients, transurethral resection of the prostate — one patient. The median time after the intervention that caused urinary incontinence was 20 [15; 26] months. The effectiveness of implantation was evaluated in 11 patients, three patients had complications preventing the use of the AUS. Median follow-up was 137 [124; 160] months. There was a statistically significant decrease in the median urine loss from 700,0 [600; 800] to 12,5 [1; 60] ml. There was also a significant reduction in the use of pads per day from 7 [7; 8] to 1 [0; 2]. Five patients did not use pads. Seven patients met the criterion of cure. Median IPSS-QoL scores decreased from 4 [4; 5] to 2 [1; 2]. After treatment, the score of the ICIQ-UI SF questionnaire was 8 [6; 10]. Complications superior to Clavien-Dindo II were noted in 8 of 14 patients. Eight patients underwent 15 revisions, six of them repeated. The AUS was partially or completely removed in six patients.Conclusions. Over a ten-year follow-up period, a significant number of patients developed complications, including those requiring removal or replacement of the AUS or its components, and therefore patients with an AUS require regular long-term follow-up. Despite a significant proportion of patients who required an AUS revision, implantation leads to a statistically significant reduction in urine loss and an improvement in the quality of life.
- Open Access
- 15 March 2021
- Published by Rostov State Medical University in Urology Herald
- Vol. 9 (1) , 14-21
Long-term efficacy and safety of artificial urinary sphincter AMS 800ТМ implantations
Долгосрочные результаты эффективности и безопасности имплантации искусственного мочевого сфинктера AMS 800 ТМ
- 15 March 2021
- Published by Rostov State Medical University in Urology Herald
- Vol. 9 (1) , 14-21
Open AccessLong-term efficacy and safety of artificial urinary sphincter AMS 800ТМ implantations
Долгосрочные результаты эффективности и безопасности имплантации искусственного мочевого сфинктера AMS 800 ТМ
- Open Access
- 30 December 2018
- Published by Publishing House ABV Press in Cancer Urology
- Vol. 14 (4) , 79-86-86
Salvage lymph node dissection in patients with oligometastatic recurrence of prostate cancer confirmed by PET-CT
Background. Due to the development of visualization methods of examination in a heterogenous group of patients with prostate cancer recurrence, it has become possible to detect cases of oligometastatic disease.The objective is to evaluate intermediate term surgical and oncological results of salvage lymph node dissection (sLND) in patients with oligometastatic recurrence of prostate cancer confirmed by positron emission tomography-computed tomography (PET-CT).Materials and methods. The experience of treatment of 13 patients with recurrent prostate cancer who underwent sLND is presented. The characteristics of patients prior to sLND, surgical and oncological results were evaluated. A comparison of sLND results after PET-CT with choline and 68Ga-prostate specific membrane antigen (68Ga-PSMA) was performed.Results. Median age was 65years (interquartile range (IQR) 59—70 years), median level of prostate-specific antigen was 2.8 ng/ml (IQR 1.3—4.6 ng/ml). Complications were observed in 4 of 13 patients (grade IIIа or lower per the Clavien—Dindo classification). Median follow-up duration was 46 months (IQR 11—50 months), response to sLND was observed in 6 patients and full response (prostate-specific antigen level 0.2 ng/ml) in 4. Median time to prescription of androgen deprivation therapy after sLND was 13.6 months (IQR 5.2—30.7 months). In 5 patients, for maximum follow-up period androgen deprivation therapy wasn’t performed. No statistically significant differences between patients who underwent sLND after PET-CT with choline and 68Ga-PSMA, were observed except for the follow-up period.Conclusion. Therefore, sLND in carefully selected patients is a safe intervention allowing to delay or fully cancel androgen deprivation therapy in the presented follow-up period.
- 30 December 2018
- Published by Publishing House ABV Press in Cancer Urology
- Vol. 14 (4) , 79-86-86
Open AccessSalvage lymph node dissection in patients with oligometastatic recurrence of prostate cancer confirmed by PET-CT
Background. Due to the development of visualization methods of examination in a heterogenous group of patients with prostate cancer recurrence, it has become possible to detect cases of oligometastatic disease.The objective is to evaluate intermediate term surgical and oncological results of salvage lymph node dissection (sLND) in patients with oligometastatic recurrence of prostate cancer confirmed by positron emission tomography-computed tomography (PET-CT).Materials and methods. The experience of treatment of 13 patients with recurrent prostate cancer who underwent sLND is presented. The characteristics of patients prior to sLND, surgical and oncological results were evaluated. A comparison of sLND results after PET-CT with choline and 68Ga-prostate specific membrane antigen (68Ga-PSMA) was performed.Results. Median age was 65years (interquartile range (IQR) 59—70 years), median level of prostate-specific antigen was 2.8 ng/ml (IQR 1.3—4.6 ng/ml). Complications were observed in 4 of 13 patients (grade IIIа or lower per the Clavien—Dindo classification). Median follow-up duration was 46 months (IQR 11—50 months), response to sLND was observed in 6 patients and full response (prostate-specific antigen level 0.2 ng/ml) in 4. Median time to prescription of androgen deprivation therapy after sLND was 13.6 months (IQR 5.2—30.7 months). In 5 patients, for maximum follow-up period androgen deprivation therapy wasn’t performed. No statistically significant differences between patients who underwent sLND after PET-CT with choline and 68Ga-PSMA, were observed except for the follow-up period.Conclusion. Therefore, sLND in carefully selected patients is a safe intervention allowing to delay or fully cancel androgen deprivation therapy in the presented follow-up period.